Cited 3 times in
Cancers and cardiovascular diseases in patients with seropositive rheumatoid arthritis treated with JAK inhibitors, biologics and conventional synthetic DMARDs
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.